Skip to main content
Margaret Koziel, MD, Infectious Disease, Cambridge, MA

MargaretJKozielMD

Infectious Disease Cambridge, MA

Chief Medical Officer, Axcella Therapeutics

Dr. Koziel is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Koziel's full profile

Already have an account?

  • Office

    840 memorial drive
    Cambridge, MA 02139
    Phone+1 617-678-3532

Education & Training

  • Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical School
    Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 1989 - 1992
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1986 - 1989
  • Geisel School of Medicine at Dartmouth
    Geisel School of Medicine at DartmouthClass of 1985
  • Beth Israel Deaconess Medical Center
    Beth Israel Deaconess Medical CenterChief Residency, Internal Medicine
  • Massachusetts General Hospital
    Massachusetts General Hospital

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1988 - 2025
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Elected Member The American Society for Clinical Investigation, 2006

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Trial Investigating Potential Treatment for Fatigue Relief in People with Long COVID Reports Results
    Trial Investigating Potential Treatment for Fatigue Relief in People with Long COVID Reports ResultsApril 14th, 2023
  • Accelerating Treatments in Long COVID: What Will It Take? The Solve M.E. / BIO Webinar Series
    Accelerating Treatments in Long COVID: What Will It Take? The Solve M.E. / BIO Webinar SeriesMarch 7th, 2023
  • Experimental Long COVID Drug Shows Promise Tackling Fatigue
    Experimental Long COVID Drug Shows Promise Tackling FatigueAugust 5th, 2022
  • Join now to see all

Grant Support

  • Immunologic Correlates Of Liver Disease ProgressionNational Institute Of Allergy And Infectious Diseases2005–2009
  • Determinants Of Liver Injury In Chronic Hepatitis C Virus InfectionNational Institute Of Allergy And Infectious Diseases2007
  • Determinants Of Liver Injury In Chronic HCV InfectionNational Institute Of Allergy And Infectious Diseases2005–2006
  • Natural Killer T Cells In An Animal Model Of Hepatitis CNational Institute Of Allergy And Infectious Diseases2004–2006
  • T Lymphocyte Apoptosis In Hepatitis C PersistenceNational Institute Of Allergy And Infectious Diseases2002–2006
  • Natural Killer T Cells In An Animal Model Of Hepatitis CNational Institute Of Allergy And Infectious Diseases2003
  • Immunity To Hepatitis C In Liver Transplant RecipientsNational Institute Of Allergy And Infectious Diseases1997–2001
  • Cellular Immunity To Hepatitis C VirusNational Institute Of Allergy And Infectious Diseases1996
  • Cellular Immunity To Hepatitis C VirusNational Institute Of Allergy And Infectious Diseases1994–1996
  • Cytotoxic T Lymphocytes In Hepatitis C Virus InfectionNational Institute Of Allergy And Infectious Diseases1991–1992